Post-hypoxic intention myoclonus treated with 5-hydroxytryptophan and an extracerebral decarboxylase inhibitor
Authors:
- 1 April 1978
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 57 (4) , 289-294
Abstract
Post‐hypoxic intention myoclonus successfully treated by long‐term administration of the combination of 5‐hydroxytryptophan and carbidopa is described. Persistent euphoria and diarrhoea were essential side effects. Methysergide (12 mg/day) blocked the therapeutic effect, indicating a specific serotoninergic function of precursor loading with 5‐hydroxytryptophan. Tryptophan (8 g/day) had no effect on the myoclonus suggesting a reduced tryptophan hydroxylase activity. Plasma concentrations of 5‐hydroxytryptophan in the range of 10–30 micromoles per liter were obtained during maintenance therapy with 900 mg 5‐hydroxytryptophan per day in combination with 150 mg carbidopa per day.Keywords
This publication has 18 references indexed in Scilit:
- CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE OXIDASE INHIBITOR, AND CLONAZEPAMBrain, 1977
- 5-Hydroxytryptophan: A method for monitoring human plasma content during clinical administrationNeurochemical Research, 1976
- L‐5‐hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominentNeurology, 1976
- Beneficial effects of serotonin precursors in postanoxic action myoclonusNeurology, 1976
- MANIPULATION OF BRAIN SEROTONIN IN THE TREATMENT OF MYOCLONUSThe Lancet, 1975
- RELIEF OF ACTION MYOCLONUS BY 5-HYDROXYTRYPTOPHANThe Lancet, 1974
- MYOCLONUS, METHYSERGIDE, AND SEROTONINThe Lancet, 1974
- DRAMATIC EFFECT OF METHYSERGIDE ON MYOCLONUSThe Lancet, 1974
- HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movementsJournal of the Neurological Sciences, 1973
- Ascending Monoamine Neurons to the Telencephalon and DiencephalonActa Physiologica Scandinavica, 1966